Pharma Journalist 8887 posts 0 comments

AbbVie has announced encouraging late-breaking results from its Phase 2 IMGN853-0420 clinical trial, showcasing the potential of mirvetuximab soravtansine-gynx in treating recurrent…
Read More...

Daiichi Sankyo and Merck & Co. (known as MSD outside the United States and Canada) have announced that the U.S. Food and Drug Administration has accepted and granted Priority Review…
Read More...

Novo Nordisk has announced a strategic partnership with OpenAI aimed at transforming healthcare through advanced artificial intelligence, with a focus on accelerating drug discovery and…
Read More...

As antibody-drug conjugates (ADCs) continue to move into more complex payload classes and higher drug–antibody ratios, linker and conjugation chemistry remains a critical bottleneck for…
Read More...

Telix Pharmaceuticals Limited has announced that the U.S. Food and Drug Administration has accepted its resubmitted New Drug Application (NDA) for TLX101-Px, an investigational imaging…
Read More...

C4 Therapeutics, Inc. has announced a new collaboration agreement with Roche to advance research in a promising cancer treatment approach known as degrader-antibody conjugates (DACs).…
Read More...

AC Immune SA has strengthened its long-standing partnership with Eli Lilly and Company through an amendment to their 2018 collaboration agreement, advancing efforts to develop novel…
Read More...

Nxera Pharma Co., Ltd. has reached a key development milestone in its ongoing collaboration with Eli Lilly and Company, advancing joint efforts to develop new treatments for diabetes…
Read More...

Sidewinder Therapeutics has raised $137 million in an oversubscribed Series B financing round, signaling strong investor confidence in its next-generation cancer treatment platform…
Read More...

Jeito Capital has successfully closed its second fund, Jeito II, raising $1.2 billion and exceeding its initial target, in a move that underscores growing investor confidence in…
Read More...